4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000078
EVP Research sold 6,305 shares at $50.42 ($317,879)
- EVP Research acquired 17,090 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Swayze Eric · EVP Research
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 1 in the form | +17,069 | 49,585 | D | ||
| 2024-01-17 | Sale : show line 2 in the form | −6,296 | $50.42 | $317,425 | 43,289 | D |
| 2024-01-16 | Exercise or conversion : show line 3 in the form | +21 | 94 | I | ||
| 2024-01-17 | Sale : show line 4 in the form | −9 | $50.42 | $454 | 85 | I |
| Open-market sales · 6,305 sh · avg $50.42 · $317,879 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-16 | Exercise or conversion : show line 5 in the form Restricted Stock Unit | −17,069 | $0.00 | 17,069 | 46,728 | D |
| 2024-01-16 | Exercise or conversion : show line 6 in the form Restricted Stock Unit | −21 | $0.00 | 21 | 551 | I |
Loading xslF345X05/edgardoc.xml…